26 September 2018 (Wednesday) - ASH Update

The American Society of Hematology sent their update today with their five most-read articles:
  1. How I Treat In Brief: Managing Monoclonal Gammopathy of Undetermined Significance
  2. Is Chronic Lymphocytic Leukemia Curable With Newer Agents?
  3. FDA Approves Ibrutinib Combo for Waldenström Macroglobulinemia
  4. Pulling Back the Curtain: Robert Glassman, MD
  5. CMS Finalizes New CAR T-Cell Payment Structure
They also gave the option to follow them on Twitter… have you ever used Twitter? I shall turn down that option…

No comments:

Post a Comment